These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29270748)

  • 21. Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression.
    Zhou X; Jiao D; Dou M; Zhang W; Lv L; Chen J; Li L; Wang L; Han X
    J Cell Mol Med; 2020 Sep; 24(18):10648-10662. PubMed ID: 32725802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering miR-4302.
    Liu W; Ma W; Yuan Y; Zhang Y; Sun S
    Biochem Biophys Res Commun; 2018 Jun; 500(4):846-851. PubMed ID: 29698681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2.
    Hou Y; Li L; Ju Y; Lu Y; Chang L; Xiang X
    J Cell Biochem; 2017 Oct; 118(10):3142-3149. PubMed ID: 27966775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
    FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
    Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
    Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
    Yamasaki T; Yoshino H; Enokida H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Fuse M; Seki N; Nakagawa M
    Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
    Yoshitomi T; Kawakami K; Enokida H; Chiyomaru T; Kagara I; Tatarano S; Yoshino H; Arimura H; Nishiyama K; Seki N; Nakagawa M
    Oncol Rep; 2011 Jun; 25(6):1661-8. PubMed ID: 21479368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
    Yuan Q; Sun T; Ye F; Kong W; Jin H
    Cancer Biomark; 2017; 19(1):93-101. PubMed ID: 28269755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERO1α mediates endoplasmic reticulum stress-induced apoptosis via microRNA-101/EZH2 axis in colon cancer RKO and HT-29 cells.
    Wang G; Han J; Wang G; Wu X; Huang Y; Wu M; Chen Y
    Hum Cell; 2021 May; 34(3):932-944. PubMed ID: 33559868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
    Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
    [TBL] [Abstract][Full Text] [Related]  

  • 35.  Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
    Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
    Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential circRNA expression profiles during the BMP2-induced osteogenic differentiation of MC3T3-E1 cells.
    Qian DY; Yan GB; Bai B; Chen Y; Zhang SJ; Yao YC; Xia H
    Biomed Pharmacother; 2017 Jun; 90():492-499. PubMed ID: 28395271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling.
    Zhang WY; Liu QH; Wang TJ; Zhao J; Cheng XH; Wang JS
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31746333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
    Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
    FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer.
    Sun J; Zhang H; Tao D; Xie F; Liu F; Gu C; Wang M; Wang L; Jiang G; Wang Z; Xiao X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1349-1356. PubMed ID: 30968727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.